Julie Smith - Insider Trading & Ownership

Entity
Individual
Location
C/O Raptor Pharmaceutical Corp, 9 Commercial Blvd, Suite 200, Novato, California
Summary
The estimated net worth of Julie Smith is at least $321 K dollars as of June 7, 2024. Julie Smith is the Director of EXELIXIS, INC. and owns shares of EXELIXIS, INC. (EXEL) stock worth about $321 K.
All Insider Reports
All Insider Reports

Ownership of Julie Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EXEL EXELIXIS, INC. Director $321 K -$576 K -64.2% May 31, 2024
STOK Stoke Therapeutics, Inc. Director Jun 5, 2024

Insider Transactions Reported by Julie Smith:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership